6-allyl-N-(1-methyl-1,2,3,4-tetrahydroquinolin-7-yl)-6H-pyrido[2,3-c]pyrimido[4,5-e][1,2]thiazin-2-amine 5,5-dioxide | 1418315-31-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 6-allyl-N-(1-methyl-1,2,3,4-tetrahydroquinolin-7-yl)-6H-pyrido[2,3-c]pyrimido[4,5-e][1,2]thiazin-2-amine 5,5-dioxide
• 英文别名: N-(1-methyl-3,4-dihydro-2H-quinolin-7-yl)-8,8-dioxo-9-prop-2-enyl-8lambda6-thia-3,5,9,11-tetrazatricyclo[8.4.0.02,7]tetradeca-1(10),2,4,6,11,13-hexaen-4-amine；N-(1-methyl-3,4-dihydro-2H-quinolin-7-yl)-8,8-dioxo-9-prop-2-enyl-8λ6-thia-3,5,9,11-tetrazatricyclo[8.4.0.02,7]tetradeca-1(10),2,4,6,11,13-hexaen-4-amine
• CAS: 1418315-31-7
• 化学式: C₂₂H₂₂N₆O₂S
• 分子量: 434.522
• InChiKey: KJIGLSANKQONAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  31
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  99.7
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• [EN] TRICYCLIC INHIBITORS OF KINASES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES<br/>[FR] INHIBITEURS TRICYCLIQUES DE KINASES UTILES POUR LE TRAITEMENT DES MALADIES PROLIFÉRATIVES
  申请人：ABBOTT LAB

  公开号：WO2013012681A1

  公开（公告）日：2013-01-24

  The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1, R2, R3, A, B, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer.

  本发明涉及式(I)的化合物或药用可接受的盐，其中R1、R2、R3、A、B和n在描述中有定义。本发明还涉及含有上述化合物的组合物，用于抑制wee-1等激酶以及治疗癌症等疾病的方法。
• TRICYCLIC INHIBITORS OF KINASES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES
  申请人：Abbvie Inc.

  公开号：EP2731953A1

  公开（公告）日：2014-05-21
• New Chemical Entities To Be Used For Wee1 Inhibition For The Treatment Of Cancer
  申请人：Woods Keith W.

  公开号：US20130018045A1

  公开（公告）日：2013-01-17

  The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R 1 , R 2 , R 3 , A, B, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as wee-1 and methods of treating diseases such as cancer.
• US8716297B2
  申请人：——

  公开号：US8716297B2

  公开（公告）日：2014-05-06